Lexicon Pharmaceuticals Langfristige Verbindlichkeiten 2011-2026 | LXRX

Langfristige Verbindlichkeiten Jährlich Lexicon Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	235 M	274 M	260 M	154 M	246 M	142 M	84.7 M	86.8 M	112 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
274 M	84.7 M	177 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.7	-1.24 %	$ 2.61 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.84	7.59 %	$ 4.58 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Axsome Therapeutics AXSM	48.9 M	$ 166.38	1.52 %	$ 8.28 B	USA
AbCellera Biologics ABCL	326 M	$ 3.82	5.82 %	$ 1.14 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Capricor Therapeutics CAPR	4.86 M	$ 26.86	-3.83 %	$ 719 M	USA
Codexis CDXS	28.2 M	$ 1.02	0.99 %	$ 74.9 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Cellectis S.A. CLLS	109 M	$ 3.8	-2.06 %	$ 116 M	France
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Collegium Pharmaceutical COLL	17.1 M	$ 41.6	-0.17 %	$ 1.32 B	USA
Corcept Therapeutics Incorporated CORT	2.29 M	$ 35.97	0.76 %	$ 3.74 B	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 23.88	3.47 %	$ 2.92 B	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Corbus Pharmaceuticals Holdings CRBP	25.1 M	$ 8.35	-2.57 %	$ 36.1 M	USA
Curis CRIS	62.5 M	$ 1.08	-5.26 %	$ 6.81 M	USA
Crinetics Pharmaceuticals CRNX	4.9 M	$ 40.68	-1.02 %	$ 3.83 B	USA
Corvus Pharmaceuticals CRVS	2.31 M	$ 17.89	-2.03 %	$ 859 M	USA
Champions Oncology CSBR	1 M	$ 6.07	2.71 %	$ 82.9 M	USA
Citius Pharmaceuticals CTXR	6.01 M	$ 0.72	-2.3 %	$ 4.84 M	USA
CEL-SCI Corporation CVM	19.5 M	$ 3.83	-10.09 %	$ 244 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Daré Bioscience DARE	1.39 M	$ 1.61	-5.29 %	$ 13.7 M	USA
DBV Technologies S.A. DBVT	7.14 M	$ 23.25	10.77 %	$ 2.26 B	France
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Precision BioSciences DTIL	62.9 M	$ 4.33	3.1 %	$ 16.6 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	264 M	$ 3.34	0.3 %	$ 1.2 M	USA
Dyadic International DYAI	8.14 M	$ 0.77	-1.68 %	$ 22.2 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Editas Medicine EDIT	186 M	$ 2.15	-2.27 %	$ 177 M	USA
Edesa Biotech EDSA	2.6 M	$ 2.28	3.64 %	$ 7.29 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	157 M	$ 29.2	-3.41 %	$ 1.69 B	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Equillium EQ	8.33 M	$ 1.92	5.49 %	$ 66.7 M	USA